The Research and Development team at Universal Cells spearheads the innovative application and enhancement of the company's genome editing technology to develop universally compatible stem cell therapies. This team, composed of highly specialized scientists and leaders in areas such as immunology, gene editing, and cell therapy, focuses on advancing the science behind immune rejection prevention, optimizing clinical processes, and managing cell therapy programs. They drive the discovery and refinement of therapeutic solutions that can be commercialized as off-the-shelf products for a wide range of patients.
View all